Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines

Japanese Journal of Cancer Research

Volumn 88, Issue 1, 1997, Pages 49-55

  Hayashi, Hisae ^a   Tatebe, Shigeru ^a   Osaki, Mitsuhiko ^a   Goto, Akira ^a   Suzuki, Yoshimasa ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Human gastric cancer cell line

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P21; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CROSS LINKING; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 0031045634     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00301.x     Document Type: Article

References (27)

1. Kerr, J. F. R., Wyllie, A. H. and Currie, A. A. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257 (1972).
2. Kerr, J. F. R., Winterford, C. M. and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73, 2013-2026 (1994).
3. Majno, G. and Joris, I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol, 146, 3-15 (1995).
4. Wyllie, A. H., Morris, R. G., Smith, A. L. and Dunlop, D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol., 142, 67-77 (1984).
5. Steller, H. Mechanisms and genes of cellular suicide. Science, 267, 1445-1449 (1995).
6. Shimamura, A. and Fisher, D. E. p53 in life and death. Clin. Cancer Res., 2, 435-440 (1996).
7. Bargou, R. C., Daniel, P. T., Mapara, M. Y., Bommert, K., Wagener, C., Kallinich, B., Royer, H. D. and Dörken, B. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60, 854-859 (1995).
8. Nagata, S. and Golstein, P. The Fas death factor. Science, 267, 1449-1456 (1995).
9. Yonehara, S., Ishii, A. and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169, 1747-1756 (1989).
10. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A. and Nagata, S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol., 148, 1274-1279 (1992).
11. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S-I., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66, 233-243 (1991).
12. Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M. and Krammer, P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305 (1989).
13. Owen-Schaub, L. B., Yonehara, S., Crump III, W. L. and Grimm, E. A. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol., 140, 197-205 (1992).
14. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S. and Taniguchi, N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol., 149, 3753-3758 (1992).
15. Itoh, N., Tsujimoto, Y. and Nagata, S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol., 151, 621-627 (1993).
16. Lacronique, V., Mignon, A., Fabre, M., Viollet, B., Rouquet, N., Molina, T., Porteu, A., Henrion, A., Bouscary, D., Varlet, P., Joulin, V. and Kahn, A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med., 2, 80-86 (1996).
17. Owen-Schaub, L. B., Radinsky, R., Kruzel, E., Berry, K. and Yonehara, S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54, 1580-1586 (1994).
18. Mattar, R., Yokozaki, H., Yasui, W., Ito, H. and Tahara, E. P53 gene mutation in gastric cancer cell lines. Oncology (Life Sci. Adv.), 11, 127-132 (1992).
19. Westendorf, J. J., Lammert, J. M. and Jelinek, D. F. Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood, 85, 3566-3576 (1995).
20. Tamura, T., Aoyama, N., Saya, H., Haga, H., Futami, S., Miyamoto, M., Koh, T., Ariyasu, T., Tachi, M., Kasuga, M. and Takahashi, R. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene, 11, 1939-1946 (1995).
21. Haapajarvi, T., Kivinen, L., Pitkanen, K. and Laiho, M. Cell cycle dependent effects of U.V.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene, 11, 151-159 (1995).
22. Rosselli, F., Ridet, A., Soussi, T., Duchaud, E., Alapetite, C. and Moustacchi, E. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene, 10, 9-17 (1995).
23. Ni, R., Tomita, Y., Matuda, K., Ichihara, A., Ishimura, K., Ogasawara, J. and Nagata, S. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res., 215, 332-337 (1994).
24. Enari, M., Hug, H. and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature, 375, 78-81 (1995).
25. Los, M., Van-de-Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W. and Schulze-Osthoff, K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature, 375, 81-83 (1995).
26. 2 in breast carcinoma cells. Oncogene, 10, 2297-2305 (1995).
27. Mapara, M. Y., Bargou, R., Zugck, C., Döhner, H., Ustaoglu, F., Jonker, R. R., Krammer, P. H. and Dörken, B. Apo-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol., 23, 702-708 (1993).